文献速递术前评估与围术期医学疼痛医学

全关节置换术后新发抑郁或焦虑的危险因素:慢性阿片类药物使用的作用

Risk factors for new-onset depression or anxiety following total joint arthroplasty: the role of chronic opioid use.
PubMed 文献 · Reg Anesth Pain Med · 2019-09-16

本研究基于Truven MarketScan数据库,纳入2012至2015年接受全髋或全膝关节置换术的106 260例手术,分析术后新发抑郁或焦虑的发生率及危险因素。结果显示新发抑郁和焦虑分别占3.6%和4.8%,术前慢性阿片使用、术后孤立使用及术后持续使用均与抑郁风险升高相关,焦虑呈现相似模式。

要点

  • 全关节置换术后新发抑郁3.6%、焦虑4.8%。
  • 术前慢性阿片使用与术后新发抑郁风险升高相关(OR 1.88)。
  • 术后孤立阿片使用与新发抑郁风险升高相关(OR 2.61)。

核心结论

  • 慢性阿片类药物使用与全关节置换术后新发抑郁或焦虑风险升高相关,但因果关系需进一步研究。

研究设计与样本

  • 基于Truven MarketScan数据库的回顾性队列研究,纳入2012至2015年106 260例全髋或全膝关节置换术(THA 34.3%,TKA 65.7%)。
  • 采用多变量logistic回归模型计算OR和95%CI。

主要发现

  • 新发抑郁和焦虑分别占3.6%和4.8%。
  • 术前慢性阿片使用(6.3%)与新发抑郁相关(OR 1.88,95%CI 1.47至2.40)。
  • 术后孤立阿片使用(10%)与新发抑郁相关(OR 2.61,95%CI 2.08至3.28)。
  • 术后持续阿片使用(7.8%)与新发抑郁相关(OR 2.08,95%CI 1.74至2.49)。
  • 女性、年轻、合并心理疾病及术后6个月内再入院也是危险因素;焦虑呈现相似模式。

临床怎么用

  • 围术期应关注全关节置换患者的慢性阿片使用史,识别术后新发抑郁或焦虑高风险人群。
  • 对术前或术后使用阿片类药物的患者,可考虑心理状态筛查与随访。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several studies have evaluated the impact of preoperative depression on outcomes following total joint arthroplasty (TJA), however few have studied new-onset depression or anxiety after TJA. We aimed to identify the incidence of and risk factors for new-onset depression/anxiety after TJA, specifically focusing on the role of chronic opioid use. METHODS: Patients who underwent total hip (THA) or total knee (TKA) arthroplasty from 2012 to 2015 were identified from the Truven MarketScan database. The main outcomes were new-onset depression or anxiety. The main risk factor of interest was chronic opioid use as a proxy for chronic pain; this was classified into three groups: isolated preoperative use, isolated postoperative use, and preoperative use that continued postoperatively. Multivariable logistic regression models were used to obtain ORs and 95% CIs. RESULTS: Overall, 106 260 TJA procedures were included (34.3% THA/65.7% TKA); new-onset depression and anxiety were observed in 3.6% and 4.8% of patients, respectively. Preoperative chronic opioid use (6.3%; OR 1.88, 95% CI 1.47 to 2.40), isolated postoperative use (10%; OR 2.61, 95% CI 2.08 to 3.28), and continued postoperative use (7.8%; OR 2.08, 95% CI 1.74 to 2.49) were all associated with significantly increased odds of new-onset depression. Additional risk factors included female gender, younger age, comorbid psychological conditions, and hospital readmission within 6 months of surgery. Similar patterns were seen for new-onset anxiety. DISCUSSION: Given the observed relationship between chronic opioid use and adverse psychological outcomes following TJA, the relationship between these two entities requires further evaluation, specifically to identify if there is a causal relationship.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Wilson L, Bekeris J, Fiasconaro M, et al. Risk factors for new-onset depression or anxiety following total joint arthroplasty: the role of chronic opioid use. Reg Anesth Pain Med. 2019. PMID: 31527160. doi:10.1136/rapm-2019-100785

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。